Establishment of the Social and Community Influences on Health Integrated Review Group, 66861 [2023-21234]
Download as PDF
<![CDATA[
ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 88, No. 187 / Thursday, September 28, 2023 / Notices
issues of data harmonization and
linkage.
2. Using RWD as part of the scientific
paradigm, including open science,
scientific rigor and reproducibility, and
team science. NIH seeks broad input on
the opportunities and challenges related
to using RWD as part of the scientific
process.
(a) Approaches or methods for using
RWD in collaborative teams and
ensuring reproducibility.
(b) How do researchers assess the
validation and verification of RWD data
that is used in research.
(c) Appropriate open science practices
and use of the FAIR principles (https://
www.nature.com/articles/sdata201618)
for research using RWD and approaches
for maximizing appropriate data sharing
when expected by the NIH Policy for
Data Management and Sharing (https://
sharing.nih.gov/data-management-andsharing-policy) or other policies.
3. Administrative and logistical
considerations for collecting, using, and
sharing RWD for biomedical and
behavioral research. NIH seeks broad
input on the opportunities and
challenges related to the process of
acquiring, using, and making RWD
available for biomedical and behavioral
research, including:
(a) Pros and cons of various
approaches for obtaining RWD through
algorithms, purchasing RWD through
trusted parties, accessing RWD through
secure enclaves, etc.
(b) Considerations regarding
licensing, costs, third party
involvement, and restrictions for data
use and sharing.
(c) Availability/utility of emerging deidentification technologies and data
storage/sharing considerations.
4. Ethical considerations for using
RWD for biomedical and behavioral
research. NIH seeks broad input on the
opportunities and challenges related to
potential bioethical issues regarding the
collection, use, and sharing of RWD,
including:
(a) Strategies for protecting
participant privacy and autonomy.
(b) Potential re-identification risks for
RWD, including the technical feasibility
of re-identifying linked data and the
possibility of anonymity for patients,
research participants, and their families.
(c) Ethical implications of data as a
‘‘commodity’’, in terms of buying and
selling personal health data.
This RFI is for planning purposes
only and should not be construed as a
solicitation for applications or
proposals, or as an obligation in any
way on the part of the United States
Government. The Government will not
pay for the preparation of any
VerDate Sep<11>2014
18:09 Sep 27, 2023
Jkt 259001
information submitted or for the
Government’s use. Additionally, the
Government cannot guarantee the
confidentiality of the information
provided.
Dated: September 21, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National
Institutes of Health.
[FR Doc. 2023–21239 Filed 9–27–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Establishment of the Social and
Community Influences on Health
Integrated Review Group
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
1001–1014), the Director, National
Institutes of Health (NIH) announces the
establishment of the Social and
Community Influences on Health
Integrated Review Group (IRG) as
authorized by 42 U.S.C. 282(b)(16),
section 402(b)(16) of the Public Health
Service Act, as amended.
The Director, NIH, has determined
that the Social and Community
Influences on Health IRG is in the
public interest in connection with the
performance of duties imposed on NIH
by law, and that these duties can best be
performed through the advice and
counsel of the committee.
The committee provides advice and
recommendations on funding
applications and proposals, including
but not limited to, the scientific and
technical merit of applications for
grants-in-aid for research, research
training, or research-related grants and
cooperative agreements, or contract
proposals relating to scientific areas
relevant to social, interpersonal,
community, and cultural influences on
health, development, and well-being
across the life span.
Inquiries may be directed to Claire
Harris, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or Claire.Harris@nih.gov.
Dated: September 21, 2023.
Lawrence A. Tabak,
Acting NIH Director, National Institutes of
Health.
[FR Doc. 2023–21234 Filed 9–27–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
66861
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Cancer Institute.
This meeting will be a hybrid meeting
held in-person and virtually and will be
open to the public as indicated below
with attendance limited to space
available. Individuals who plan to
attend in-person or view the virtual
meeting and need special assistance or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting. The
open session can be accessed from the
NIH Videocast at the following link:
https://videocast.nih.gov/.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Cancer Institute, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: November 13, 2023.
Open: 10:00 a.m. to 10:30 a.m.
Agenda: Remarks from the NCI Director.
Closed: 10:30 a.m. to 4:00 p.m.
Agenda: Personnel qualifications and
performance, and competence of individual
investigators.
Name of Committee: Board of Scientific
Counselors, National Cancer Institute.
Date: November 14, 2023.
Closed: 11:00 a.m. to 1:45 p.m.
Agenda: Personnel qualifications and
performance, and competence of individual
investigators.
Place: National Institute of Health,
Building 31, C Wing, 6th Floor, Conference
Room C, 9000 Rockville Pike, Bethesda, MD
20892 (Hybrid Meeting).
Contact Person: Brian E. Wojcik, Ph.D.,
Senior Review Administrator, Institute
Review Office, Office of the Director,
National Cancer Institute, National Institutes
of Health, 9609 Medical Center Drive, Room
3W414, Rockville, MD 20850, 240–276–5660,
wojcikb@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
E:\FR\FM\28SEN1.SGM
28SEN1
]]>Agencies
[Federal Register Volume 88, Number 187 (Thursday, September 28, 2023)]
[Notices]
[Page 66861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21234]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Establishment of the Social and Community Influences on Health
Integrated Review Group
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. 1001-1014), the Director, National Institutes of Health (NIH)
announces the establishment of the Social and Community Influences on
Health Integrated Review Group (IRG) as authorized by 42 U.S.C.
282(b)(16), section 402(b)(16) of the Public Health Service Act, as
amended.
The Director, NIH, has determined that the Social and Community
Influences on Health IRG is in the public interest in connection with
the performance of duties imposed on NIH by law, and that these duties
can best be performed through the advice and counsel of the committee.
The committee provides advice and recommendations on funding
applications and proposals, including but not limited to, the
scientific and technical merit of applications for grants-in-aid for
research, research training, or research-related grants and cooperative
agreements, or contract proposals relating to scientific areas relevant
to social, interpersonal, community, and cultural influences on health,
development, and well-being across the life span.
Inquiries may be directed to Claire Harris, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
[email protected].
Dated: September 21, 2023.
Lawrence A. Tabak,
Acting NIH Director, National Institutes of Health.
[FR Doc. 2023-21234 Filed 9-27-23; 8:45 am]
BILLING CODE 4140-01-P
